Physician profile
Crystal V Walker
NPI 1508074105
$2,439.90
in general payments reported to CMS, 2019-2025
20 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $298 · 2021: $291 · 2022: $244 · 2023: $359 · 2024: $342 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $505.14 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $269.33 | 2019-2025 | Camzyos, Eliquis |
| Astellas Pharma US INC | $260.52 | 2019-2021 | |
| Pfizer INC. | $235.76 | 2019-2025 | |
| Preventice Services, LLC | $190.22 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.17 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $127.63 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $108.10 | 2021-2025 | Verquvo |
| Amgen INC. | $100.24 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $93.89 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.62 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $69.07 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $51.23 | 2019-2021 | |
| Abbott Laboratories | $50.02 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $34.82 | 2023 | Inpefa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $21.41 | 2025 | Wegovy |
| Siemens Medical Solutions USA, INC. | $18.20 | 2021 | |
| Esperion Therapeutics, INC. | $17.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.69 | 2025 | |
| Irhythm Technologies, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.